5 premarket notifications (510(k)s) from applicants based in Nebraska were decided by FDA in the last 12 months, newest first. Each row links to FDA's own record.
| Decided | Applicant | Device | Area | Where | Record |
|---|---|---|---|---|---|
| 2026-08-20 | Virtual Incision | MIRA Surgical System SAB | General, Plastic Surgery | Lincoln, Nebraska | K260817 |
| 2026-03-27 | Streck, LLC | MDx-Chex for BCP PMN | Microbiology | La Vista, Nebraska | K260041 |
| 2026-03-23 | Streck | MDx-Chex for BCN PMN | Microbiology | La Vista, Nebraska | K254166 |
| 2026-03-17 | Streck, LLC | MDx-Chex for BCY PMN | Microbiology | La Vista, Nebraska | K254167 |
| 2026-01-12 | Empower Ride, LLC | EmpowerRide NAVIGATOR IOR | Physical Medicine | Elkhorn, Nebraska | K251886 |
Where this comes from
Before most medical devices can be sold in the United States, the maker submits a premarket notification, a 510(k), and FDA decides whether the device is substantially equivalent to one already on the market. Every row here is one of those decisions, linked to FDA's own record of it. The product area is the medical specialty FDA files the device under; the location is the applicant's, as the submission gives it.
A clearance means the agency found the device substantially equivalent; it is not an endorsement. Where an applicant also files with the SEC under the same name in the same state, it links to that company's page.
Cite this page
https://mentionfox.com/fda/510k/state/ne